Sa1854 Effects of a Narrow Spectrum Kinase Inhibitor (NSKI) and Selective Kinase Inhibitors on the Intestinal Pro-Inflammatory Immune Response in Ulcerative Colitis

2016 ◽  
Vol 150 (4) ◽  
pp. S382
Author(s):  
Martyn Foster ◽  
Paolo Biancheri ◽  
Yemisi Solanke ◽  
Sameer Sirohi ◽  
Matthew C. Fyfe ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Immune Response ◽  
Kinase Inhibitors ◽  
Kinase Inhibitor ◽  
Narrow Spectrum ◽  
Inflammatory Immune Response

scholarly journals Effect of Narrow Spectrum Versus Selective Kinase Inhibitors on the Intestinal Proinflammatory Immune Response in Ulcerative Colitis

2016 ◽  
Vol 22 (6) ◽  
pp. 1306-1315 ◽  
Author(s):  
Paolo Biancheri ◽  
Martyn R. Foster ◽  
Matthew C. T. Fyfe ◽  
Thomas T. MacDonald ◽  
Sameer Sirohi ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Immune Response ◽  
Kinase Inhibitors ◽  
Narrow Spectrum ◽  
Spectrum Versus

scholarly journals P684 A first clinical trial of a novel narrow spectrum kinase inhibitor TOP1288 in patients with ulcerative colitis

2017 ◽  
Vol 11 (suppl_1) ◽  
pp. S429-S430 ◽  
Author(s):  
M. Taylor ◽  
A. Duggal ◽  
A. Rowley ◽  
M. Foster ◽  
S. Sirohi ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Clinical Trial ◽  
Kinase Inhibitor ◽  
Narrow Spectrum
Sign in / Sign up

Export Citation Format

Share Document